findmyKOL

James Grotta, MD

Basic profile

Memorial Hermann

ORCIDNPI
RegionHouston, TX · South CentralSpecialtyNeurologyFocusNeurology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2023Online presenceNot yet checkedPayments2021 onwardNIH funding1985–2012

James Grotta is a Neurology physician affiliated with Memorial Hermann. OpenAlex indexes 906 publications with 53,422 citations (h-index 118); ClinicalTrials.gov lists 4 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Neurology profiles in the findmyKOL directory.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
906publications

Distinct works indexed by OpenAlex, matched via ORCID.

53,422citations

Total citations across indexed works.

118h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
4clinical trials

Investigator role on registered studies.

View trials
10companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments
6NIH grants · 1985–2012

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

6410 Fannin St
1014
Houston, TX 770303000

Telephone

832-325-7080

Provider last certified this registry record 16 Sept 2024.

View the NPPES registry record

Clinical trials

2 more trial records behind the reveal.Reveal →

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Industry payments

10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2022)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    55%
    Other antiepileptics33.3%
    Levetiracetam100%
    Part D<11 patients
    Mood Stabilizer21.7%
    Lamotrigine100%
    Part D<11 patients
  • Blood & clotting

    45%
    Factor Xa inhibitor23.3%
    Eliquis100%
    Part D<11 patients
    P2Y12 inhibitor21.7%
    Clopidogrel100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

6 NIH research awards on record, funded 19852012 per NIH RePORTER. The latest:

73 more award records behind the reveal.Reveal →

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”